Obesity News

DENVER — Obesity prevalence is increasing among reproductive-age people and unhealthy weight is associated with infertility in both sexes, yet the impact of weight reduction on fertility outcomes is complex, according to a speaker.

Oral semaglutide demonstrated an approximately 14% reduction in major adverse CV events compared with standard care along in patients with diabetes, CVD and/or kidney disease, according to the top-line results of the phase 3 SOUL trial.

At current prices, bariatric surgery was more cost-effective than GLP-1 receptor agonists for treatment of obesity, researchers reported at the American College of Surgeons Clinical Congress.

BOSTON — In a survey, cardiology physicians expressed hesitancy to prescribe currently available obesity medications, preferring exercise and dietary interventions, but with little personalized tailoring for patients, researchers reported.

Ozempic and similar drugs for diabetes and weight-related conditions were associated with a 40% lower rate of opioid overdose and 50% lower rate of alcohol intoxication in people with opioid and alcohol use disorders, a new study showed.

The 19th annual Cardiometabolic Health Congress will be held at the Boston Park Plaza and will feature the latest science in the areas of cardio-renal, obesity, diabetes and dyslipidemia, atherosclerosis, thrombosis and more.

Among younger women in the Middle East, those with overweight or obesity were more likely to have hypertension, diabetes and pregnancy-related issues than those without it, according to data from the ANCORS-YW study.

Adolescents with obesity prescribed a GLP-1 receptor agonist are less likely to have suicidal ideation or a suicide attempt than those with obesity treated with lifestyle intervention, according to new data.

Exposure to higher levels of some types of per-and polyfluoroalkyl substances, or PFAS, may lead to shorter sleep duration and sleep disruptions for certain young adults, according to findings published in Environmental Advances.

Adults with obesity who underwent bariatric surgery were less likely to develop pancreatic cancer than those who with obesity who did not have bariatric surgery, researchers reported.